Louis P Lacasse - Net Worth and Insider Trading
Louis P Lacasse Net Worth
The estimated net worth of Louis P Lacasse is at least $453,537 dollars as of 2024-11-13. Louis P Lacasse is the Director of Conatus Pharmaceuticals Inc and owns about 809,887 shares of Conatus Pharmaceuticals Inc (CNAT) stock worth over $453,537. Details can be seen in Louis P Lacasse's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Louis P Lacasse has not made any transactions after 2013-07-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Louis P Lacasse
Louis P Lacasse Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Louis P Lacasse owns 2 companies in total, including Histogen Inc (HSTO) , and Armata Pharmaceuticals Inc (ARMP) .
Click here to see the complete history of Louis P Lacasse’s form 4 insider trades.
Insider Ownership Summary of Louis P Lacasse
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| HSTO | Histogen Inc | 2013-07-24 | director |
| ARMP | Armata Pharmaceuticals Inc | 2004-05-20 | director |
Louis P Lacasse Latest Holdings Summary
Louis P Lacasse currently owns a total of 1 stock. Louis P Lacasse owns 809,887 shares of Conatus Pharmaceuticals Inc (CNAT) as of July 30, 2013, with a value of $453,537.
Latest Holdings of Louis P Lacasse
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNAT | Conatus Pharmaceuticals Inc | 2013-07-30 | 809,887 | 0.56 | 453,537 |
Holding Weightings of Louis P Lacasse
Louis P Lacasse Form 4 Trading Tracker
According to the SEC Form 4 filings, Louis P Lacasse has made a total of 0 transactions in Conatus Pharmaceuticals Inc (CNAT) over the past 5 years. The most-recent trade in Conatus Pharmaceuticals Inc is the acquisition of 123,950 shares on July 30, 2013, which cost Louis P Lacasse around $1 Million.
Insider Trading History of Louis P Lacasse
- 1
Louis P Lacasse Trading Performance
GuruFocus tracks the stock performance after each of Louis P Lacasse's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Louis P Lacasse is -2.19%. GuruFocus also compares Louis P Lacasse's trading performance to market benchmark return within the same time period. The performance of stocks bought by Louis P Lacasse within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Louis P Lacasse's insider trading performs compared to the benchmark.
Performance of Louis P Lacasse
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -0.66 | | | | | |
| Relative Return to S&P 500(%) | 2.48 | | | | | |
Louis P Lacasse Ownership Network
Ownership Network List of Louis P Lacasse
Ownership Network Relation of Louis P Lacasse
Louis P Lacasse Owned Company Details
What does Histogen Inc do?
Who are the key executives at Histogen Inc?
Louis P Lacasse is the director of Histogen Inc. Other key executives at Histogen Inc include See Remarks Joyce Reyes , director & See Remarks Richard W Pascoe , and See Remarks Moya Daniels .
Histogen Inc (HSTO) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Histogen Inc (HSTO) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Histogen Inc (HSTO) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Histogen Inc (HSTO)'s detailed insider trading history can be found in Insider Trading Tracker table.
Histogen Inc Insider Transactions
Louis P Lacasse Mailing Address
Above is the net worth, insider trading, and ownership report for Louis P Lacasse. You might contact Louis P Lacasse via mailing address: Targeted Genetics Corp, 1100 Olive Way Ste 100, Seattle Wa 98101.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
